Surmodics Reports Second Quarter Fiscal 2020 Results and Provides COVID-19 Pandemic Update
Surmodics, Inc. (SRDX)
Last surmodics, inc. earnings: 4/29 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
surmodics.gcs-web.com/investor-overview
Company Research
Source: Business Wire
EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced results for its fiscal 2020 second quarter ended March 31, 2020, and suspended its financial guidance for fiscal 2020.Summary of Second Quarter and Recent HighlightsRevenue of $22.8 million, an increase of 1% year-over-yearGAAP EPS of $0.11, non-GAAP EPS of $0.04Cash and short-term investments of $48.4 millionCE Mark clearance received for Telemark™ coronary/peripheral support microcatheterPartnership announced with Cook Medical for commercialization of .014” and .018” low-profile PTA balloon catheters“Our customers depend on Surmodics as a critical supplier, with thousands of vital medical device procedures and in vitro diagnostic tests relying on our products every day. The health and safety of our employees is our top priority, and I want to thank our team for their courage and commitment thro
Show less
Read more
Impact Snapshot
Event Time:
SRDX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SRDX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SRDX alerts
High impacting Surmodics, Inc. news events
Weekly update
A roundup of the hottest topics
SRDX
News
- Surmodics gains as FTC won't appeal denial of GTCR deal injunction [Seeking Alpha]Seeking Alpha
- Surmodics Announces FTC Does Not Intend to Appeal Denial of Injunction, Order Preventing Closing Set to Expire Today [Yahoo! Finance]Yahoo! Finance
- Surmodics Announces FTC Does Not Intend to Appeal Denial of Injunction, Order Preventing Closing Set to Expire TodayBusiness Wire
- Surmodics (NASDAQ:SRDX) was downgraded by analysts at Barrington Research from a "market perform" rating to an "underperform" rating.MarketBeat
- Judge denies FTC's bid to block $627M Surmodics buyout [Yahoo! Finance]Yahoo! Finance
SRDX
Earnings
- 8/8/25 - Beat
SRDX
Sec Filings
- 11/20/25 - Form SCHEDULE
- 11/19/25 - Form 4
- 11/19/25 - Form 4
- SRDX's page on the SEC website